NA
TWST icon

NewEdge Advisors’s Twist Bioscience TWST Stock Holding History

NewEdge Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$19K – 4389
2026
Q1 		$19K Sell
400
-5
-1% -$224 ﹤0.01% 3209
2025
Q4 		$12.8K Buy
405
+5
+1% +$156 ﹤0.01% 3393
2025
Q3 		$11.3K Hold
400
– – ﹤0.01% 3299
2025
Q2 		$14.7K Hold
400
– – ﹤0.01% 3054
2025
Q1 		$15.7K Hold
400
– – ﹤0.01% 2944
2024
Q4 		$18.6K Sell
400
-135
-25% -$6.1K ﹤0.01% 2830
2024
Q3 		$24.2K Sell
535
-20
-4% -$952 ﹤0.01% 2665
2024
Q2 		$27.4K Buy
555
+3
+0.5% +$122 ﹤0.01% 2528
2024
Q1 		$18.9K Hold
552
– – ﹤0.01% 2650
2023
Q4 		$20.3K Hold
552
– – ﹤0.01% 2568
2023
Q3 		$11.2K Hold
552
– – ﹤0.01% 2539
2023
Q2 		$11.3K Sell
552
-25
-4% -$375 ﹤0.01% 2559
2023
Q1 		$8.7K Sell
577
-96
-14% -$2.12K ﹤0.01% 2605
2022
Q4 		$2.3K Buy
+673
New +$19.5K ﹤0.01% 2803

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

NewEdge Advisors's TWST Position: Q2 2026 in Review

NewEdge Advisors sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 400 shares — an estimated $19K sold.

NewEdge Advisors first reported a position in TWST in Q4 2022 and held it in 14 quarters. The position peaked at $27.4K in Q2 2024. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • NewEdge Advisors reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • NewEdge Advisors sold 400 Twist Bioscience shares in Q2 2026, an estimated $19K.
  • NewEdge Advisors first reported a position in Twist Bioscience in Q4 2022 and held it in 14 quarters.
  • NewEdge Advisors's Twist Bioscience position peaked at $27.4K in Q2 2024.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.